Tenax Therapeutics Inc (TENX)

Finanzdaten der Tenax Therapeutics Inc-Aktie (TENX)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	100.00% -	6.6819	4.2348	2.4723	3.0789
Operating Expenses	16.98% 3.9083	3.3409	2.1174	1.2362	1.5395
Interest Income/Expense	269.68% 0.00796	0.00215	0.00534	0.00913	0.00735
Depreciation and Amortization	100.00% -	0.00471	0.000969	0.001	0.000895
Operating Income/Loss	216.98% -3.9083	3.3409	2.1174	1.2362	1.5395
Income/Loss From Continuing Operations Before Tax	17.77% -3.7988	-3.2256	1.972	-1.1063	-1.4068
Income/Loss From Continuing Operations After Tax	17.77% -3.7988	-3.2256	1.972	-1.1063	-1.4068
Net Income/Loss	17.77% -3.7988	-3.2256	1.972	-1.1063	-1.4068
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	17.77% -7.5977	-6.4512	-	-	-
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-